On the heels of unprompted EMA review of Covid drug, FDA schedules adcomm for potential EUA
The FDA is now following through on an emergency use filing for a repurposed cancer drug that European regulators initially took an interest in. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
